Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories geographic Revenue — United States ($M) ($M)
Postgres DB segment_values + Form 10-K Segment & Geographic Footnote
Latest, FY2025
17,126
Period ended Dec 31, 2025
Change on a year earlier
+4.9%
16,323 in FY2024
History
16 years
Since FY2010
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Geographic Revenue — United States ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17,126 | +4.9% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 16,323 | +5.6% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 15,452 | -14.8% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 18,142 | +9.0% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 16,642 | +27.8% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 13,022 | +14.2% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 11,398 | +5.2% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 10,839 | +12.1% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 9,673 | +49.1% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 6,486 | +3.4% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 6,270 | +2.4% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 6,123 | -1.4% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 6,208 | -0.5% | Form 10-K (filed 2015-02-27) ↗ |
| FY2012 | Dec 31, 2012 | 6,242 | -1.0% | Form 10-K (filed 2015-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 6,302 | -58.5% | Form 10-K (filed 2014-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 15,194 | – | Form 10-K (filed 2013-02-15) ↗ |
Breakdown
What makes up geographic revenue — united states ($m)
- Geographic Revenue — Germany ($M)2,759 · FY2025
- Geographic Revenue — China ($M)1,907 · FY2025
- Geographic Revenue — Japan ($M)1,475 · FY2025
- Geographic Revenue — India ($M)1,871 · FY2025
- Geographic Revenue — Switzerland ($M)1,871 · FY2025
- Geographic Revenue — Netherlands ($M)1,124 · FY2024
- Geographic Revenue — All Other Countries ($M)15,979 · FY2025
- Long-Lived Assets — United States ($M)11,900 · FY2025
- Long-Lived Assets — International ($M)0 · FY2025
Cite this data
StockData. (2026). Abbott Laboratories Geographic Revenue — United States ($M) ($M), annual FY2010–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-geo-us
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.